Tip-offs for when CEOs lie
A new study offers insights into when CEOs are fibbing. But those who benefit most from the revelations might be their handlers.
Public Companies
Articles
Equity firm withdraws support for revised Emmis deal
A Monday morning announcement from Alden Global Capital puts CEO Jeff Smulyan’s efforts to take Emmis private in real jeopardy.
His attempts to sway preferred shareholders already have failed five times.
Endocyte’s $86M IPO plan a boon for Indiana, investors
Venture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.
Strong Shoe Carnival profit beats estimates
Sales of toning footwear helped the Evansville-based company post record earnings in its fiscal second quarter.
Cancer drug developer Endocyte files for IPO
The company, headquartered at Purdue Research Park, said the number of shares to be offered and their price range have yet
to be determined.
Steak n Shake parent sees profit, revenue rise
Biglari Holdings Inc. said revenue in the quarter rose 9.4 percent over the year-ago period and same-store sales increased by 7.5 percent
Will third time be a charm for Emmis?
Emmis shareholders are set to vote again Friday night on taking the company private, but the proposal could be in jeopardy
if a deal is not reached
soon, says one investment expert.
Eli Lilly loses patent lawsuit for Strattera
Eli Lilly and Co. on Thursday lowered its revenue outlook for the year after it lost a patent lawsuit over its attention
deficit hyperactivity drug Strattera. The patent had been set to expire in May 2017. Lilly plans to appeal.
AIG sells American General unit to Fortress at loss
American International Group Inc. has agreed to sell a majority stake in its Evansville-based consumer lending unit, getting
rid of an operation that posted about $1.7 billion in operating losses since 2008 and accumulated more than $17 billion in
debt.
FinishMaster reports lower sales, profit
The Indianapolis-based distributor of automotive paints and accessories reported that its second-quarter profit dipped nearly
2 percent, to $3.7 million, from the same period a year earlier.
Noble Roman’s quarterly profit, revenue slips
Noble Roman’s Inc. profit and revenue slipped in the second quarter as fewer of its traditional Noble’s Pizza
and Tuscano’s Italian Style Subs stores were operating.
Steak n Shake parent postpones meeting amid pay uproar
San Antonio-based Biglari Holdings Inc. said late Monday it will delay a planned Aug. 24 shareholder meeting to give the company
time to
address “misinformation” regarding its CEO’s controversial pay package.
WellPoint boosts debt offering to $1 billion
Proceeds from the sale will be used for working capital and general corporate purposes, including debt repayment, the company
said in a prospectus.
Arcadia sees smaller loss, extends WellPoint pact
Indianapolis-based health care firm reaches agreement to offer its DailyMed product to more WellPoint Inc. health plan members.
Finish Line founders giving up their extra voting power
The influence of founders’ families in public companies usually wanes over time. But few firms accelerate the process,
as Finish Line is doing.
New store openings drive HHGregg profit
Indianapolis-based appliance and electronics retailer opened 26 new stores in its fiscal first quarter and earned $2.7 million
in profit.
Kite Realty Group reports lower funds from operations
Indianapolis-based developer said the loss reflected slower construction activity and lower profit on land and outlet sales.
Occupancy at its retail centers increased, however, to 91 percent.
Brightpoint boosts revenue, profit
Brightpoint Inc. on Wednesday reported second-quarter revenue of $788.6 million as the Indianapolis company continued to grow
its share of the wireless device distribution business.
Court defeat lost in Lilly’s gloomy long-term outlook
Eli Lilly and Co.’s loss of a patent on one of its blockbuster drugs in court late last month received a collective yawn
from
investors, who have shunned the stock because of five looming patent expirations.
Smulyan considering another option to take Emmis private
The communications company said in a news release that CEO Jeff Smulyan is continuing to negotiate with a group of preferred
shareholders
and is considering another buyout option that would not require their consent.